COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,653 Articles (22,459 medRxiv, 8,194 bioRxiv)

Most recent first Previous |  Page 38: Articles 371-380  | Next

Longitudinal analysis of antibody titers after primary and booster mRNA COVID-19 vaccination can identify individuals at risk for breakthrough infection
Park, H., Nakamura, N., Miyamoto, S., Sato, Y., Kim, K. S., Kitagawa, K., Kobashi, Y., Tani, Y., Shimazu, Y., Zhao, T., Nishikawa, Y., Omata, F., Kawashima, M., Abe, T., Saito, Y., Nonaka, S., Takita, M., Yamamoto, C., Morioka, H., Kato, K., Sagou, K., Yagi, T., Kawamura, T., Sugiyama, A., Nakayama, A., Kaneko, Y., Shibata, R. Y., Aihara, K., Kodama, T., Kamiyama, A., Tamura, T., Fukuhara, T., Shibuya, K., Suzuki, T., Iwami, S., Tsubokura, M.
10.1101/2025.03.01.639360 — Posted: 2025-03-03
Global Distribution of Coronaviruses among Bat Populations detected using Molecular techniques, A Systematic Review
Mulemena, J. A., Sichamba, P., Muleya, W., Mubemba, B., Chitanga, S., Simulundu, E., Changula, K.
10.1101/2025.03.01.640975 — Posted: 2025-03-02
Cryo-ET of IgG bivalent binding on SARS-CoV-2 provides structural basis for antibody avidity
Yao, H., Song, Y., Huang, Q., Zhu, M., Liang, J., Zhang, Z., Zhang, X., Dong, D., Shi, D., Wu, Z., Lu, X., Wu, H., Chen, Y., Li, S.
10.1101/2025.02.28.640788 — Posted: 2025-03-02
A curriculum learning approach to training antibody language models
Burbach, S. M., Briney, B.
10.1101/2025.02.27.640641 — Posted: 2025-03-02
Higher-Order Biomarkers Through Network Motif Mining: A COVID-19 Case Study
Chahley, N., Murira, A., Nakhla, N., Oliver, C.
10.1101/2025.02.27.638877 — Posted: 2025-03-02
Variant connective tissue as a risk factor for Long COVID: a case-control study
Torok, R. A., Lubell, J., Rudy, R. M., Eccles, J. A., Quadt, L.
10.1101/2025.02.27.25323047 — Posted: 2025-03-01
Knowledge, Attitudes and Acceptance of COVID-19 Vaccine among Pregnant Women in Mbeya Region
Kabanga, R. L., Chambo, V. J., Mokeha, R.
10.1101/2025.02.26.25322935 — Posted: 2025-02-28
Investigation of coronaviruses, paramyxoviruses and poxviruses in free-ranging anteaters and armadillos: a search for the unknown and zoonotic implications
Martins, N. B., Alves, M. H., De Navasquez, L. M. L., Linhares, Y. S., Caiaffa, M. G., Soresini, G., Kluyber, D., Yogui, D. R., Alves, A. C., Lobo, A. C. M., Catao-Dias, J. L., Benavides, J. A., Desbiez, A. L. J., Brandao, P. E., Hora, A. S. d.
10.1101/2025.02.26.640290 — Posted: 2025-02-28
Preclinical evaluation of the efficacy of α-Difluoromethylornithine and Sulindac against SARS-CoV-2 infection
Ignatenko, N. A., Trinh, H., Wagner, A. M., Gerner, E. W., Bime, C., Hsu, C.-H., Besselsen, D. G.
10.1101/2025.02.26.640194 — Posted: 2025-02-28
Construction and characterization of coronavirus nonstructural protein 3-host protein interaction networks unravel an important role of cleavage and polyadenylation specificity factor 6 in regulation of viral RNA replication
Sun, X., Yuan, L. X., Hu, Z., Lai, Y., Yang, B., He, J., Chen, R., Liu, D.
10.1101/2025.02.27.640555 — Posted: 2025-02-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).